Peripheral blood natural killer cell proportion and ovarian function in women with recurrent implantation failure

Reference

• Gougeon A, Lefevre B. Histological evidence of alternating ovulation in women. J Reprod Fertil. 1984;70(1):7–13.
   PubMedGoogle Scholar
• Broer SL, Broekmans FJ, Laven JS, et al. Anti-Mullerian hormone: ovarian reserve testing and its potential clinical implications. Hum Reprod Update. 2014;20(5):688–701.
   PubMed Web of Science ®Google Scholar
• Grynnerup AG, Lindhard A, Sorensen S. The role of anti-Mullerian hormone in female fertility and infertility – an overview. Acta Obstet Gynecol Scand. 2012;91(11):1252–1260.
   PubMed Web of Science ®Google Scholar
• Nair S, Slaughter JC, Terry JG, et al. Anti-Mullerian hormone (AMH) is associated with natural menopause in a population-based sample: The CARDIA Women’s Study. Maturitas. 2015;81(4):493–498.
   PubMed Web of Science ®Google Scholar
• Dewailly D, Andersen CY, Balen A, et al. The physiology and clinical utility of anti-Mullerian hormone in women. Hum Reprod Update. 2014;20(3):370–385.
   PubMed Web of Science ®Google Scholar
• Dolleman M, Verschuren WM, Eijkemans MJ, et al. Reproductive and lifestyle determinants of anti-Mullerian hormone in a large population-based study. J Clin Endocrinol Metab. 2013;98(5):2106–2115.
   PubMed Web of Science ®Google Scholar
• Dunlop CE, Anderson RA. Uses of anti-Mullerian hormone (AMH) measurement before and after cancer treatment in women. Maturitas. 2015;80(3):245–250.
   PubMed Web of Science ®Google Scholar
• Su HC, Haunschild C, Chung K, et al. Prechemotherapy anti-Mullerian hormone, age, and body size predict timing of return of ovarian function in young breast cancer patients. Cancer. 2014;120(23):3691–3698.
   PubMed Web of Science ®Google Scholar
• de Kat AC, van der Schouw YT, Eijkemans MJ, et al. Back to the basics of ovarian aging: a population-based study on longitudinal anti-Mullerian hormone decline. BMC Med. 2016;14(1):151.
   PubMedGoogle Scholar
• Muzii L, Di Tucci C, Di Feliciantonio M, et al. The effect of surgery for endometrioma on ovarian reserve evaluated by antral follicle count: a systematic review and meta-analysis. Hum Reprod. 2014;29(10):2190–2198.
   PubMed Web of Science ®Google Scholar
• Vega M, Barad DH, Yu Y, et al. Anti-Mullerian hormone levels decline with the presence of antiphospholipid antibodies. Am J Reprod Immunol. 2016;76(4):333–337.
   PubMed Web of Science ®Google Scholar
• Kwak-Kim J, Gilman-Sachs A. Clinical implication of natural killer cells and reproduction. Am J Reprod Immunol. 2008;59(5):388–400.
   PubMed Web of Science ®Google Scholar
• Hoek A, van Kasteren Y, de Haan-Meulman M, et al. Analysis of peripheral blood lymphocyte subsets, NK cells, and delayed type hypersensitivity skin test in patients with premature ovarian failure. Am J Reprod Immunol. 1995;33(6):495–502.
   PubMed Web of Science ®Google Scholar
• Tanaka E, Sendo F, Kawagoe S, et al. Decreased natural killer cell activity in women with endometriosis. Gynecol Obstet Invest. 1992;34(1):27–30.
   PubMed Web of Science ®Google Scholar
• Anderson RA, Anckaert E, Bosch E, et al. Prospective study into the value of the automated Elecsys anti-Müllerian hormone assay for the assessment of the ovarian growing follicle pool. Fertil Steril. 2015;103(4):1074–1080.e4.
   PubMed Web of Science ®Google Scholar
• Kim JO, Lee WS, Lee BE, et al. Interleukin-1beta -511T > C genetic variant contributes to recurrent pregnancy loss risk and peripheral natural killer cell proportion. Fertil Steril. 2014;102(1):206–212 e5.
   PubMed Web of Science ®Google Scholar
• Lee JE, Park DS, Kim M-L, et al. Age-related distribution of anti-Müllerian hormone levels in 2,879 Korean women with regular menstruation. Korean J Obstet Gynecol. 2012;55(12):920.
   Google Scholar
• Gao H, Ma J, Wang X, et al. Preliminary study on the changes of ovarian reserve, menstruation, and lymphocyte subpopulation in systemic lupus erythematosus (SLE) patients of childbearing age. Lupus. 2018;27(3):445–453.
   PubMed Web of Science ®Google Scholar
• Fainaru O, Hantisteanu S, Rotfarb N, et al. Maturation of human ovarian follicles is accompanied by a decrease in the CD56 + CD16+ natural killer cell population. Fertil Steril. 2011;95(7):2395–2398.
   PubMed Web of Science ®Google Scholar
• Thum MY, Bhaskaran S, Bansal AS, et al. Simple enumerations of peripheral blood natural killer (CD56+ NK) cells, B cells and T cells have no predictive value in IVF treatment outcome. Hum Reprod. 2005;20(5):1272–1276.
   PubMed Web of Science ®Google Scholar
• Thum MY, Bhaskaran S, Abdalla HI, et al. An increase in the absolute count of CD56dimCD16 + CD69+ NK cells in the peripheral blood is associated with a poorer IVF treatment and pregnancy outcome. Hum Reprod. 2004;19(10):2395–2400.
   PubMed Web of Science ®Google Scholar
• Fukui A, Kamoi M, Funamizu A, et al. NK cell abnormality and its treatment in women with reproductive failures such as recurrent pregnancy loss, implantation failures, preeclampsia, and pelvic endometriosis. Reprod Med Biol. 2015;14(4):151–157.
   PubMedGoogle Scholar